Glenmark Pharmaceuticals Limited: Detailed financials

Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.

Company financials

Particulars	Dec-24	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26	Sep-26
	3,388	3,256	3,264	6,047	3,901	3,771	4,018	4,157
	31	12	26	201	44	189	66	93
	2,962	2,887	2,872	3,895	3,227	3,199	3,441	3,628
	746	795	732	723	775	731	601	838
	418	345	581	620	749	446	661	530
	−80	−51	−298	−78	−229	−5	−16	−62
	788	737	763	1,086	841	887	935	1,028
	52	67	58	66	41	43	54	64
	123	125	130	141	154	148	173	180
	915	870	906	1,337	894	948	1,033	1,050
	631	200	284	1,175	730	578	871	582
	509	75	154	1,034	575	430	697	402
	—	−373	−323	−1,385	−184	−373	—	−284
	456	8	96	967	534	388	643	338
	108	4	49	357	131	86	161	74
	348	4	47	610	403	301	483	264
Financial ratios
	18.64%	6.14%	8.69%	19.43%	18.71%	15.34%	21.66%	14.01%
	10.27%	0.13%	1.44%	10.09%	10.34%	7.99%	12.02%	6.35%
	12.33	0.16	1.66	21.63	14.29	10.68	17.11	9.35

Revenue

₹ crore

Select any table row to compare its reported history.

Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.